Opening book details…
Can I read Optimizing the "Drug-Like" Properties of Leads in Drug Discovery (Biotechnology: Pharmaceutical Aspects Book 4) on EtoBox?
Optimizing the "Drug-Like" Properties of Leads in Drug Discovery (Biotechnology: Pharmaceutical Aspects Book 4) by Dhiren R. Thakker (auth.), Ronald T. Borchardt, Edward H. Kerns, Michael J. Hageman, Dhiren R. Thakker, James L. Stevens (eds.) is a medicine available to read on EtoBox.
What is Optimizing the "Drug-Like" Properties of Leads in Drug Discovery (Biotechnology: Pharmaceutical Aspects Book 4) about?
Drug discovery and development is a very complex, costly, and ti- consuming process. Because of the uncertainties associated with predicting the pharmacological effects and the toxicity characteristics of new chemical entities in man, their clinical development is quite prone to failure. In recent years, phar- ceutical companies have come under increasing pressure to introduce new blockbuster drugs into the marketplace more rapidly. Companies have responded to these pressures by introducing new
Who reads Optimizing the "Drug-Like" Properties of Leads in Drug Discovery (Biotechnology: Pharmaceutical Aspects Book 4)?
It is typically read by working professionals who need an authoritative practice reference.
Common subject areas: medicine, law, business, engineering.
- Author
- Dhiren R. Thakker (auth.), Ronald T. Borchardt, Edward H. Kerns, Michael J. Hageman, Dhiren R. Thakker, James L. Stevens (eds.)
- Publisher
- Springer-Verlag New York
- Published
- 2006
- Language
- EN
- ISBN
- 9786611180652
- Category
- medicine
- Subjects
- Science, Chemistry, Medical
- Rating
- 4 / 5 (1 ratings)
- Updated
- 2026-03-25
More by Dhiren R. Thakker (auth.), Ronald T. Borchardt, Edward H. Kerns, Michael J. Hageman, Dhiren R. Thakker, James L. Stevens (eds.)
Similar books
- Nanotechnology in Drug Delivery (Biotechnology: Pharmaceutical Aspects (X)) — Daniel P. Otto, Melgardt M. de Villiers (auth.), Melgardt M. de Villiers, Pornanong Aramwit, Glen S. Kwon (2009)
- Integration of Pharmaceutical Discovery and Development: Case Histories (Pharmaceutical Biotechnology (11)) — Ralph Hirschmann (auth.), Ronald T. Borchardt, Roger M. Freidinger, Tomi K. Sawyer, Philip L. Smith (2002)
- Drug-Drug Interactions in Pharmaceutical Development (Wiley Series in Drug Discovery and Development) — Binghe Wang; Albert P. Li (2007)
- Functional Informatics in Drug Discovery (Drug discovery series ; 9) — edited by Sergey Ilyin (2007)
- Microdialysis in Drug Development (AAPS Advances in the Pharmaceutical Sciences Series Book 4) — Markus Müller (auth.) (2013)
- Successful Drug Discovery, Volume 4 — János Fischer, Christian Klein, Wayne E. Childers, David P. Rotella (2019)